Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoping Cui

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Stroke and Vascular Neurology|May 30, 2020
Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in ChinaHuaguang Zheng, Yi Yang, Huisheng Chen, et al.
Nature|September 28, 2007
Rag mutations reveal robust alternative end joiningBarbara Corneo, Rebecca L Wendland, Ludovic Deriano, et al.
Signal Transduction and Targeted Therapy|October 7, 2020
The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case seriesHao Zeng, Dongfang Wang, Jingmin Nie, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Stroke and Vascular Neurology|May 30, 2020
Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in ChinaHuaguang Zheng, Yi Yang, Huisheng Chen, et al.
Nature|September 28, 2007
Rag mutations reveal robust alternative end joiningBarbara Corneo, Rebecca L Wendland, Ludovic Deriano, et al.
Signal Transduction and Targeted Therapy|October 7, 2020
The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case seriesHao Zeng, Dongfang Wang, Jingmin Nie, et al.
Pageof 4